Evidence map›Paper›PMID 37446714›Full record

ReviewMolecules (Basel, Switzerland)2023

From Bench to Bedside: What Do We Know about Imidazothiazole Derivatives So Far?

Mu Guo, Xiangbin Yu, Yi Zhun Zhu, Yue Yu

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mu GuoSchool of Pharmacy, Fujian Medical University, Fuzhou 350122, China.ORCID 0009-0004-6462-0687
Xiangbin YuSchool of Pharmacy, Fujian Medical University, Fuzhou 350122, China.
Yi Zhun ZhuSchool of Pharmacy, Macau University of Science and Technology, Macau 999078, China.ORCID 0000-0001-7700-8041
Yue YuSchool of Pharmacy, Fujian Medical University, Fuzhou 350122, China.ORCID 0000-0001-7905-6733

Funding

Fujian University Industry University Cooperation Project 2021Y4011Scientific Research Initiation Fund of Fujian Medical University XRCZX202205
6 · The paper itself

Abstract

Imidazothiazole derivatives are becoming increasingly important in therapeutic use due to their outstanding physiological activities. Recently, applying imidazothiazole as the core, researchers have synthesized a series of derivatives with biological effects such as antitumor, anti-infection, anti-inflammatory and antioxidant effects. In this review, we summarize the main pharmacological effects and pharmacological mechanisms of imidazothiazole derivates; the contents summarized herein are intended to advance the research and rational development of imidazothiazole-based drugs in the future.

Indexed as

ThiazolesThiazolescondensed heterocyclic compoundsdruggable candidatesimidazothiazoleslevamisolepharmacological effect

Identifiers

PMID37446714
PMCPMC10343371

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.